DE3500103C2 - - Google Patents

Info

Publication number
DE3500103C2
DE3500103C2 DE3500103A DE3500103A DE3500103C2 DE 3500103 C2 DE3500103 C2 DE 3500103C2 DE 3500103 A DE3500103 A DE 3500103A DE 3500103 A DE3500103 A DE 3500103A DE 3500103 C2 DE3500103 C2 DE 3500103C2
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3500103A
Other versions
DE3500103A1 (de
Inventor
Bernd Stockebrand
Peter Christian Prof. Dr. 3550 Marburg De Schmidt
Gerhard Dr. 6930 Eberbach De Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Germany Eberbach GmbH
Original Assignee
Catalent Germany Eberbach GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Germany Eberbach GmbH filed Critical Catalent Germany Eberbach GmbH
Priority to DE19853500103 priority Critical patent/DE3500103A1/de
Priority to US06/814,483 priority patent/US4727109A/en
Publication of DE3500103A1 publication Critical patent/DE3500103A1/de
Application granted granted Critical
Publication of DE3500103C2 publication Critical patent/DE3500103C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
DE19853500103 1985-01-04 1985-01-04 Pharmazeutische zubereitung mit einem in wasser und verdauungssaeften schwer loeslichen wirkstoff Granted DE3500103A1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE19853500103 DE3500103A1 (de) 1985-01-04 1985-01-04 Pharmazeutische zubereitung mit einem in wasser und verdauungssaeften schwer loeslichen wirkstoff
US06/814,483 US4727109A (en) 1985-01-04 1985-12-30 Pharmaceutical preparation with an active substance of low solubility in water and gastric juices

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853500103 DE3500103A1 (de) 1985-01-04 1985-01-04 Pharmazeutische zubereitung mit einem in wasser und verdauungssaeften schwer loeslichen wirkstoff

Publications (2)

Publication Number Publication Date
DE3500103A1 DE3500103A1 (de) 1986-07-10
DE3500103C2 true DE3500103C2 (de) 1987-01-22

Family

ID=6259234

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853500103 Granted DE3500103A1 (de) 1985-01-04 1985-01-04 Pharmazeutische zubereitung mit einem in wasser und verdauungssaeften schwer loeslichen wirkstoff

Country Status (2)

Country Link
US (1) US4727109A (de)
DE (1) DE3500103A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA875317B (en) * 1986-08-01 1988-01-25 Warner-Lambert Company Transdermal compositions
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
HU196559B (en) * 1987-04-17 1988-12-28 Biogal Gyogyszergyar Process for production of capsules of big stability from mild gelatine for medical purpuses containing as active substance of oils of natural origin
FI96169C (fi) * 1989-07-10 1996-05-27 Eisai Co Ltd Menetelmä polyprenyyliyhdistettä sisältävän farmaseuttisen koostumuksen valmistamiseksi
US5258185A (en) * 1989-08-23 1993-11-02 Bauer Kurt H Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
AU2517095A (en) * 1994-05-19 1995-12-18 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
NZ280610A (en) * 1994-12-29 1997-08-22 Mcneil Ppc Inc Soft gelatin-like pharmaceutical carrier: gelled polyethylene glycol and dispersed active agent
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US6982281B1 (en) * 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US20070092559A1 (en) * 2005-10-24 2007-04-26 Jinghua Yuan Liquid dosage forms having enteric properties of delayed and then sustained release
CA2718416C (en) * 2008-03-13 2018-01-02 Mallinckrodt Inc. Multi-function, foot-activated controller for imaging system
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US10028965B2 (en) 2013-05-24 2018-07-24 Icon Bioscience, Inc. Use of sustained release dexamethasone in post-cataract surgery inflammation
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197369A (en) * 1962-02-15 1965-07-27 Scherer Gmbh R P Coated gelatin capsules
NL148500B (nl) * 1967-10-07 1976-02-16 Scherer Gmbh R P Depotgeneesmiddelen in capsulevorm.
US4198391A (en) * 1973-07-20 1980-04-15 R. P. Scherer Ltd. Pharmaceutical compositions
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
GB1590864A (en) * 1978-05-16 1981-06-10 Lilly Industries Ltd Thixotropic filling medium for hard gelatin capsules
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
US4605548A (en) * 1983-05-31 1986-08-12 Nitto Electric Industrial Co., Ltd. Drug administration material
US4595583A (en) * 1984-03-19 1986-06-17 Alza Corporation Delivery system controlled administration of beneficial agent to ruminants

Also Published As

Publication number Publication date
DE3500103A1 (de) 1986-07-10
US4727109A (en) 1988-02-23

Similar Documents

Publication Publication Date Title
DE3500103C2 (de)
DE8630759U1 (de)
DE8507818U1 (de)
DE3590781T1 (de)
DE3510109C2 (de)
DE8526686U1 (de)
DE3690630T1 (de)
DE8530214U1 (de)
DE3518012C2 (de)
DE8505050U1 (de)
DE8531411U1 (de)
DE8517157U1 (de)
DE8504102U1 (de)
DE8525928U1 (de)
DE8516751U1 (de)
AU4121285A (de)
AU3954685A (de)
DE8504950U1 (de)
DE8504152U1 (de)
DE8501335U1 (de)
DE8529736U1 (de)
CA1270854C (de)
BG45177A1 (de)
BG44792A1 (de)
BG44841A1 (de)

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8363 Opposition against the patent
8331 Complete revocation